AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Satralizumab in Nigeria
1 product registered with NAFDAC — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Enspryng Solution for Injection** Solution for injection | A6-100128 | Roche Products Limited | active | 30 Aug 2028 |
Satralizumab — NAFDAC Registration Details
NAFDAC (Nigeria) has 1 registered product containing Satralizumab, of which 1 is currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Satralizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.